Drug Profile


Alternative Names: HOE 234; Rimalkalim

Latest Information Update: 26 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Antiasthmatics; Antihypertensives; Bronchodilators; Chromans; Pyrrolidines; Small molecules
  • Mechanism of Action KATP channel stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Coronary disorders

Most Recent Events

  • 19 Apr 2000 Discontinued-I for Asthma in Germany (unspecified route)
  • 01 Nov 1996 A preclinical study has been added to the Obstructive Airways Disease pharmacodynamics section
  • 16 Mar 1995 Discontinued-Unspecified Phase in Coronary disorders in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top